RxSight, Inc. (RXST) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Lose.
28/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseRXST / S&P -21.75% / 15.20% |
LoseRXST / S&P -17.66% / 15.00% |
LoseRXST / S&P 41.25% / 50.40% |
| 2026-Q11/3 |
LoseRXST / S&P -40.88% / -4.33% |
LoseRXST / S&P -14.05% / 11.30% |
WinRXST / S&P 68.66% / 27.70% |
| 2025-Q42/3 |
WinRXST / S&P 15.91% / 2.65% |
LoseRXST / S&P -3.89% / 9.00% |
WinRXST / S&P 31.94% / 13.40% |
| 2025-Q31/3 |
LoseRXST / S&P -30.85% / 8.12% |
WinRXST / S&P 10.75% / 4.61% |
LoseRXST / S&P 7.32% / 13.45% |
| 2025-Q21/3 |
LoseRXST / S&P -48.51% / 10.94% |
WinRXST / S&P 27.68% / 4.83% |
LoseRXST / S&P -20.79% / 10.63% |
| 2025-Q11/3 |
LoseRXST / S&P -26.56% / -4.27% |
WinRXST / S&P 46.69% / 4.98% |
LoseRXST / S&P -46.40% / 10.57% |
| 2024-Q41/3 |
LoseRXST / S&P -30.45% / 2.41% |
WinRXST / S&P 57.08% / 5.25% |
LoseRXST / S&P -49.30% / 6.15% |
| 2024-Q31/3 |
LoseRXST / S&P -17.85% / 5.89% |
WinRXST / S&P 67.51% / 5.89% |
LoseRXST / S&P -52.33% / 6.11% |
| 2024-Q22/3 |
WinRXST / S&P 16.65% / 4.28% |
WinRXST / S&P 71.90% / 5.38% |
LoseRXST / S&P -48.99% / 5.12% |
| 2024-Q12/3 |
WinRXST / S&P 27.93% / 10.56% |
WinRXST / S&P 75.67% / 5.71% |
LoseRXST / S&P -42.92% / 5.59% |
| 2023-Q42/3 |
WinRXST / S&P 44.57% / 11.69% |
WinRXST / S&P 81.77% / 6.81% |
LoseRXST / S&P -41.08% / 7.78% |
| 2023-Q33/3 |
WinRXST / S&P -3.16% / -3.27% |
WinRXST / S&P 85.25% / 7.52% |
WinRXST / S&P -2.82% / -5.03% |
| 2023-Q23/3 |
WinRXST / S&P 72.66% / 8.74% |
WinRXST / S&P 94.13% / 9.50% |
WinRXST / S&P 7.61% / -8.57% |
| 2023-Q12/3 |
WinRXST / S&P 31.65% / 7.50% |
WinRXST / S&P 105.17% / 10.77% |
LoseRXST / S&P -53.99% / -15.69% |
| 2022-Q41/3 |
LoseRXST / S&P 5.58% / 7.56% |
WinRXST / S&P 116.90% / 11.88% |
LoseRXST / S&P RXST unavailable / -17.99% |
| 2022-Q31/3 |
LoseRXST / S&P -14.77% / -4.88% |
WinRXST / S&P 116.67% / 13.47% |
LoseRXST / S&P RXST unavailable / -1.41% |
| 2022-Q22/3 |
WinRXST / S&P 13.73% / -16.10% |
WinRXST / S&P 97.62% / 13.71% |
LoseRXST / S&P RXST unavailable / 11.04% |
| 2022-Q12/3 |
WinRXST / S&P 10.04% / -4.60% |
WinRXST / S&P 83.65% / 15.97% |
LoseRXST / S&P RXST unavailable / 42.23% |
| 2021-Q40/3 |
LoseRXST / S&P -11.21% / 11.03% |
LoseRXST / S&P RXST unavailable / 15.00% |
LoseRXST / S&P RXST unavailable / 96.40% |
| 2021-Q30/3 |
LoseRXST / S&P RXST unavailable / 0.58% |
LoseRXST / S&P RXST unavailable / 10.77% |
LoseRXST / S&P RXST unavailable / 69.42% |
| 2021-Q20/3 |
LoseRXST / S&P RXST unavailable / 8.55% |
LoseRXST / S&P RXST unavailable / 6.58% |
LoseRXST / S&P RXST unavailable / 51.81% |
| 2021-Q10/3 |
LoseRXST / S&P RXST unavailable / 6.17% |
LoseRXST / S&P RXST unavailable / -1.06% |
LoseRXST / S&P RXST unavailable / 7.39% |
| 2020-Q40/3 |
LoseRXST / S&P RXST unavailable / 12.15% |
LoseRXST / S&P RXST unavailable / -3.72% |
LoseRXST / S&P RXST unavailable / -33.42% |
| 2020-Q30/3 |
LoseRXST / S&P RXST unavailable / 8.93% |
LoseRXST / S&P RXST unavailable / -2.04% |
LoseRXST / S&P RXST unavailable / -27.10% |
| 2020-Q20/3 |
LoseRXST / S&P RXST unavailable / 20.54% |
LoseRXST / S&P RXST unavailable / -0.46% |
LoseRXST / S&P RXST unavailable / -27.11% |
| 2020-Q10/3 |
LoseRXST / S&P RXST unavailable / -19.60% |
LoseRXST / S&P RXST unavailable / 3.47% |
LoseRXST / S&P RXST unavailable / -14.75% |
| 2019-Q40/3 |
LoseRXST / S&P RXST unavailable / 9.07% |
LoseRXST / S&P RXST unavailable / 5.36% |
LoseRXST / S&P RXST unavailable / 2.99% |
| 2019-Q30/3 |
LoseRXST / S&P RXST unavailable / 1.70% |
LoseRXST / S&P RXST unavailable / 5.02% |
LoseRXST / S&P RXST unavailable / 0.21% |
| 2019-Q20/3 |
LoseRXST / S&P RXST unavailable / 4.30% |
LoseRXST / S&P RXST unavailable / 6.64% |
LoseRXST / S&P RXST unavailable / 8.65% |
| 2019-Q10/3 |
LoseRXST / S&P RXST unavailable / 13.65% |
LoseRXST / S&P RXST unavailable / 8.12% |
LoseRXST / S&P RXST unavailable / 14.29% |
| 2018-Q40/3 |
LoseRXST / S&P RXST unavailable / -13.52% |
LoseRXST / S&P RXST unavailable / 9.05% |
LoseRXST / S&P RXST unavailable / 18.23% |
| 2018-Q30/3 |
LoseRXST / S&P RXST unavailable / 7.71% |
LoseRXST / S&P RXST unavailable / 10.21% |
LoseRXST / S&P RXST unavailable / 19.06% |
| 2018-Q20/3 |
LoseRXST / S&P RXST unavailable / 3.43% |
LoseRXST / S&P RXST unavailable / 9.03% |
LoseRXST / S&P RXST unavailable / 14.46% |
| 2018-Q10/3 |
LoseRXST / S&P RXST unavailable / -0.76% |
LoseRXST / S&P RXST unavailable / 7.68% |
LoseRXST / S&P RXST unavailable / 12.46% |
| 2017-Q40/3 |
LoseRXST / S&P RXST unavailable / 6.64% |
LoseRXST / S&P RXST unavailable / 7.03% |
LoseRXST / S&P RXST unavailable / 13.82% |
| 2017-Q30/3 |
LoseRXST / S&P RXST unavailable / 4.48% |
LoseRXST / S&P RXST unavailable / 5.68% |
LoseRXST / S&P RXST unavailable / 17.57% |
| 2017-Q20/3 |
LoseRXST / S&P RXST unavailable / 3.09% |
LoseRXST / S&P RXST unavailable / 4.83% |
LoseRXST / S&P RXST unavailable / 17.74% |
| 2017-Q10/3 |
LoseRXST / S&P RXST unavailable / 6.07% |
LoseRXST / S&P RXST unavailable / 3.67% |
LoseRXST / S&P RXST unavailable / 13.32% |
| 2016-Q40/3 |
LoseRXST / S&P RXST unavailable / 3.82% |
LoseRXST / S&P RXST unavailable / 2.09% |
LoseRXST / S&P RXST unavailable / 7.05% |
| 2016-Q30/3 |
LoseRXST / S&P RXST unavailable / 3.85% |
LoseRXST / S&P RXST unavailable / 0.20% |
LoseRXST / S&P RXST unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | RXST total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -26.88% | 20.78% |
| Annualized return | -26.88% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | RXST total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -58.08% | 83.14% |
| Annualized return | -15.96% | 12.86% |
10Y · 2021-07-30 to 2026-08-27
| Metric | RXST total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -58.69% | 319.30% |
| Annualized return | -8.46% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |